Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
NCT ID: NCT05821075
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1/PHASE2
90 participants
INTERVENTIONAL
2023-08-24
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prednisone Treatment for Vestibular Neuronitis
NCT00271791
Glucocorticosteroid Treatment in Acute Unilateral Vestibulopathy (Vestibular Neuronitis)
NCT05024448
Scandinavian Bell's Palsy Study
NCT00510263
Acute Unilateral Vestibulopathy and Corticosteroid Treatment
NCT02912182
Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
NCT07116811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prednisolone
Prednisolone
prednisolone 60mg tablet once daily for 5 days then tapering dose
Cerebrolysin
Cerebrolysin
intramuscular Cerebrolysin 10 mg daily for 3 weeks
Prednisolone and Cerebrolysin
Prednisolone
prednisolone 60mg tablet once daily for 5 days then tapering dose
Cerebrolysin
intramuscular Cerebrolysin 10 mg daily for 3 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prednisolone
prednisolone 60mg tablet once daily for 5 days then tapering dose
Cerebrolysin
intramuscular Cerebrolysin 10 mg daily for 3 weeks
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnancy
* Diabetes
* Epilepsy
* Severe hypertension,
* Renal or hepatic disease,
* Gastric or duodenal ulcer
* presence of acute otitis media or ipsilateral chronic otitis
* Recent head injury,
* psychiatric disease
* If there is any contraindications for corticosteroids
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
October 6 University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
engy wahsh
LECTURER OF CLINICAL PHARMACY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
October 6 university hospital
Giza, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Abdelmaksod Mohammed Mousa, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRC-Ph-2211038
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.